Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procrit vs No Procrit in ALL, LL, or Burkitt's
NCT01099202Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2003
- Primary completion
- May 2011
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in anemia, sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2003; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01099202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099202.